Systemic lupus erythematosus and COVID-19 during pregnancy

Hieronymus Tw Smeele1, Luis F Perez-Garcia1, Koen Grimminck1,2

  • 1Department of Rheumatology, Erasmus University Medical Center, Rotterdam, The Netherlands.

Lupus
|March 15, 2021
PubMed

Insights

Pregnant patients with systemic lupus erythematosus (SLE) experiencing mild COVID-19 infection can often be managed with watchful waiting. Both pregnancies resulted in healthy term neonates, emphasizing individualized care during the pandemic.

Area of Science:

  • Obstetrics and Gynecology
  • Rheumatology
  • Infectious Diseases

Background:

  • The COVID-19 pandemic presents unique challenges for pregnant individuals, particularly those with autoimmune conditions like systemic lupus erythematosus (SLE).
  • Limited data exists on the clinical presentation and management of COVID-19 in pregnant SLE patients.

Observation:

  • This report details two pregnant patients with SLE who contracted mild symptomatic COVID-19.
  • A conservative watchful-waiting approach was adopted for COVID-19 management in both cases, without initiating specific antiviral treatments.

Findings:

  • Both pregnancies proceeded without adverse events, culminating in the delivery of healthy neonates at full term.
  • One patient experienced a lupus flare, potentially linked to the temporary discontinuation of SLE treatment.

Implications:

  • Multidisciplinary collaboration and individualized treatment are crucial for managing pregnant SLE patients during the COVID-19 pandemic.
  • Decisions regarding immunosuppressive therapy in pregnant SLE patients with COVID-19 should be made on a case-by-case basis, balancing risks and benefits.
  • Treatment strategies must align with current guidelines for rheumatic diseases and pregnancy during infectious disease outbreaks.

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
555
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
1.1K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.7K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
472
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
573
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.7K